Table 2 Baseline characteristics of patients with atrial fibrillation with and without oral anticoagulation in 2014
With OAC (N = 82,331) | Without OAC (N = 30,229) | |
|---|---|---|
Age (mean ± SD) | 77.12 ± 8.75 | 76.41 ± 12.42 |
Sex (percent male) | 47.7% | 46.6% |
CHA2DS2-VASc-score (mean ± SD) | 4.66 ± 1.57 | 4.25 ± 1.81 |
Hypertension | 91.6% | 85.0% |
Chronic heart failure | 47.7% | 40.2% |
Stroke or transient ischemic attack in 2014 | 10.1% | 7.96% |
Stroke in 2014 | 6.4% | 4.71% |
Diabetes mellitus | 44.3% | 10.1% |
Vascular disease | 50.6% | 12.0% |
Alcohol-related disorder | 3.2% | 5.2% |
Dementia | 11.3% | 19.2% |
Anemia | 16.2% | 19.9% |
Renal disease | 32.8% | 31.90% |
Dialysis | 0.9% | 2.5% |
Liver disease | 15.7% | 15.0% |